Peripheral Artery Disease Risk in Patients Infected With HIV, HCV
Investigators analyzed the relationship between HIV, hepatitis C virus, and peripheral artery disease in women.
Peripheral Artery Disease
Perfusion Assessment Key for Critical Limb Ischemia Diagnosis
Strategies for perfusion assessment necessary for critical limb ischemia (CLI) diagnosis remain limited.
AHA Releases Statement on Perfusion Assessment in Critical Limb Ischemia
This scientific statement released by the American Heart Association covers noninvasive assessment of limb perfusion, including limitations associated with currently available technology.
Is It Time for Endocrinologists to Join the Vascular Care Team?
As the link between diabetes and PAD becomes more evident, clinicians can best serve patients with these comorbidities by working collaboratively to prevent serious complications.
FDA: Potential Increased Mortality With Paclitaxel-Coated Balloons, Stents for PAD
The FDA’s communication follows a recent meta-analysis published in the Journal of the American Heart Association.
Peripheral Artery Disease: Incidence and Outcomes of Myocardial Infarction
Myocardial infarction was associated with an increased risk of cardiovascular death and
acute limb ischemia in patients with peripheral artery disease.
ACC, AHA Publish Appropriate Use Criteria Guidelines for Peripheral Artery Intervention
In publishing updated appropriate use criteria, the organizations hope to provide guidance to clinicians who may refer patients for revascularization therapy.
Calcium Channel Blockers May Reduce Peripheral Arterial Disease Risk in Hypertensive Patients
Meta-analysis suggests that calcium channel blockers can be effective in preventing peripheral arterial disease in patients with hypertension.
FDA Approves Eluvia Drug-Eluting Stent for Peripheral Artery Disease
The Eluvia stent is designed to release paclitaxel for a 1-year time frame to prevent tissue regrowth that might otherwise block the stented artery.
Anti-Nicotine Monoclonal Antibody Gets Orphan Drug Status for Buerger’s Disease
Buerger’s disease is a nonatherosclerotic, segmental inflammatory disorder that affects small and medium vessels of the upper and lower extremities and is strongly associated with tobacco exposure.
Next post in Vascular Medicine
